Product Images Deferoxamine Mesylate

Deferoxamine Mesylate Injection, USP is available in 500 mg vials for subcutaneous, intramuscular, or intravenous administration. It contains 500 mg of Dferoxamine mesylate USP in lyophilized form. ApoPharma produces and distributes the product, which should be reconstituted with sterile water for injection before use. The recommended dosage is a single 500 mg vial. The product should be stored at controlled room temperature and kept out of the reach of children. Validated aseptic conditions should be maintained during reconstitution, and reconstituted solutions should not be refrigerated but used within 24 hours. Detailed instructions are provided in the package insert.*

This is a product description for Deferoxamine Mesylate for Injection produced by ApoPharma. The injection is designed for subcutaneous, intramuscular, or intravenous administration. Each vial contains 2g of lyophilized Deferoxamine Mesylate USP. The recommended dosage is 2g for each day of use. The injection must be stored between 20-25 degrees Celsius and in a controlled room environment. The product can be identified through its NDC number of 5200845043 for use with a prescription only.*